Cigna Group (CI)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

• 年次報告書（10-K）

  事業内容、財務実績、リスクをまとめた年次の概要。

  提出日: 2026-02-26

  書類を見る

• 四半期報告書（10-Q）

  直近3か月間の業績に関する最新情報。

  提出日: 2026-07-30

  書類を見る

• 臨時報告書（8-K）

  経営陣の交代や重要な発表など、大きな出来事に関するお知らせ。

  提出日: 2026-09-30

  書類を見る

• 23d agoNEUTRAL
  Cigna Healthcare on Business Strategy

  Jason Sadler, International Health Global President at Cigna Healthcare, provided insights into the company's business strategy, addressing the dual forces of increasing AI adoption and escalating healthcare expenditures. While the discussion highlights Cigna's navigation of these significant industry trends, it does not present specific financial figures or forward-looking guidance that would indicate a definitive positive or negative impact on the company's immediate stock performance. Investors will monitor Cigna's strategic execution in response to these evolving market dynamics.

• 5/22/2026NEUTRAL
  Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years

  An analysis of The Cigna Group's stock performance over the past two decades reveals a significant historical return for investors. While specific figures are not detailed in this summary, the article implies substantial long-term gains. This historical perspective is crucial for investors evaluating Cigna's potential for future growth and stability, offering insights into its resilience and market position through various economic cycles. The focus remains on past performance rather than current catalysts.

• 3/6/2026POSITIVE
  Here's How Much $1000 Invested In Cigna Group 15 Years Ago Would Be Worth Today

  An investment of $1000 in Cigna Group 15 years ago would have grown to approximately $10,500 today, representing a substantial return on investment. This performance highlights the company's long-term growth trajectory and its ability to generate significant shareholder value over an extended period. Investors who held Cigna stock through various market cycles would have benefited from its strategic initiatives and market positioning within the health insurance and services sector. The impressive growth suggests a robust business model and effective management.

• 3/3/2026NEGATIVE
  Cigna Stock Falls After CEO Retirement Announcement

  Shares of The Cigna Group (NYSE:CI) experienced a significant decline on Tuesday, following the announcement of CEO David Cordani's retirement. The news immediately triggered a negative market reaction, highlighting investor sensitivity to leadership changes in major corporations. Cordani, a key figure for the healthcare giant, leaves a void that generates uncertainty about the company's future strategic and operational direction. Analysts suggest that the leadership transition could lead to a period of volatility for the stock, as the market awaits clarity on subsequent plans and the identity of the successor. For investors, this event underscores the importance of managerial stability in complex sectors like healthcare.

• 3/3/2026NEUTRAL
  Cigna’s longtime CEO to step down as health insurers face growing scrutiny

  Cigna Group, a major player in the health insurance sector, has announced a significant leadership transition. David Cordani, who has served as CEO for an impressive 27 years, will step down. He will be succeeded by Brian Evanko, a seasoned company veteran, ensuring a degree of continuity in leadership. This change comes at a time when health insurers are facing increased scrutiny, adding complexity to the new CEO's mandate. For investors, the appointment of an internal successor like Evanko suggests a focus on stability and a continuation of existing strategies, potentially mitigating immediate market volatility. However, the broader industry challenges mean Evanko will need to navigate a demanding regulatory and competitive landscape, making his strategic direction crucial for Cigna's future performance.